Sex-Related Differences in Gene Expression by Porcine Aortic Valvular Interstitial Cells
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
While many large-scale risk factors for calcific aortic valve disease (CAVD) have been identified, the molecular etiology and subsequent pathogenesis of CAVD have yet to be fully understood. Specifically, it is unclear what biological phenomena underlie the significantly higher occurrence of CAVD in the male population. We hypothesized the existence of intrinsic, cellular-scale differences between male and female valvular interstitial cells (VICs) that contribute to male sex being a risk factor for CAVD. Differences in gene expression profiles between healthy male and female porcine VICs were investigated via microarray analysis. Mean expression values of each probe set in the male samples were compared to the female samples, and biological processes were analyzed for overrepresentation using Gene Ontology term enrichment analysis. There were 183 genes identified as significantly (fold change>2; P<0.05) different in male versus female aortic valve leaflets. Within this significant gene list there were 298 overrepresented biological processes, several of which are relevant to pathways identified in CAVD pathogenesis. In particular, pathway analysis indicated that cellular proliferation, apoptosis, migration, ossification, angiogenesis, inflammation, and extracellular matrix reorganization were all significantly represented in the data set. These gene expression findings also translated into functional differences in VIC behavior in the in vitro environment, as sex-related differences in proliferation and apoptosis were confirmed in VIC populations cultured in vitro. These data suggest that a sex-related propensity for CAVD exists on the cellular level in healthy subjects, a phenomenon that could have significant clinical implications. These findings also strongly support discontinuing the use of mixed-sex VIC cultures, thereby changing the current standard in the field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Clinical Factors Associated With Calcific Aortic Valve Disease
Stewart, B. F., Siscovick, D., Lind, B. K., Gardin, J. M., Gottdiener, J. S., Smith, V. E., Kitzman, D. W., & Otto, C. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00563-3 · Cited by 2,029 · cited 3×
“CAVD can also be associated with deposition and oxidation of low density lipoprotein (LDL) cholesterol [2,17,18], and elevated LDL in the blood has also been identified as a CAVD risk factor [3,21].”
Freeman, R. V., & Otto, C. M. (2005) · Circulation · doi:10.1161/circulationaha.104.486738 · Cited by 1,006 · cited 6×
“Calcific aortic valve disease (CAVD) is defined by nonrheumatic calcification and thickening of the aortic valve leaflets and can range from pre-clinical sclerosis to symptomatic stenosis [1,2].”
InfluentialRajamannan, N. M., Evans, F. J., Aikawa, E., Grande-Allen, K. J., Demer, L. L., Heistad, D. D., Simmons, C. A., Masters, K. S., Mathieu, P., O'Brien, K. D., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.006767 · Cited by 842
Self-citationThe Role of Angiopoietin-Like Proteins in Angiogenesis and Metabolism
Hato, T., Tabata, M., & Oike, Y. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2007.10.003 · Cited by 351 · cited 1×
“Increased angiogenesis potential in male valves is further supported by the identification of VEGF in Network #1 (Table 2 and Figure 3), and the distinct downregulation of the angiogenesis modulator angiopoietin-related protein 4 (ANGPTL4) in male samples compared to female samples (Figure 1) [37].”
Kaden, J. J., Dempfle, C.-E., Grobholz, R., Tran, H.-T., Kılıç, R., Sarıkoç, A., Brueckmann, M., Vahl, C., Hagl, S., Haase, K. K., et al. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00284-3 · Cited by 272
Bossé, Y., Miqdad, A., Fournier, D., Pépin, A., Pibarot, P., & Mathieu, P. (2009) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.108.820795 · Cited by 148 · cited 7×
“Such differences in inflammation can also significantly influence other cellular processes such as proliferation, migration, and recruitment of additional inflammatory cells [16], all basic functions that are known to be upregulated in diseased valves compared to noncalcified valves [22].”
Influential
Cited by
Valve Interstitial Cells: The Key to Understanding the Pathophysiology of Heart Valve Calcification
Rutkovskiy, A., Malashicheva, A., Sullivan, G., Bogdanova, M., Kostareva, A., Stensløkken, K., Fiane, A., & Vaage, J. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006339 · Cited by 358
Aortic Valve Stenosis: From Basic Mechanisms to Novel Therapeutic Targets
Goody, P. R., Hosen, M. R., Christmann, D., Niepmann, S. T., Zietzer, A., Adam, M., Bönner, F., Zimmer, S., Nickenig, G., & Jansen, F. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.313067 · Cited by 331
Simard, L., Côté, N., Dagenais, F., Mathieu, P., Couture, C., Trahan, S., Bossé, Y., Mohammadi, S., Pagé, S., Joubert, P., et al. (2017) · Circulation Research · doi:10.1161/circresaha.116.309306 · Cited by 294
Age, Sex, and Valve Phenotype Differences in Fibro‐Calcific Remodeling of Calcified Aortic Valve
Voisine, M., Hervault, M., Shen, M., Boilard, A., Filion, B., Rosa, M., Bossé, Y., Mathieu, P., Côté, N., & Clavel, M. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015610 · Cited by 124
Multi-Omics Approaches to Define Calcific Aortic Valve Disease Pathogenesis
Blaser, M. C., Kraler, S., Lüscher, T. F., & Aikawa, E. (2021) · Circulation Research · doi:10.1161/circresaha.120.317979 · Cited by 109
Genes that escape X chromosome inactivation modulate sex differences in valve myofibroblasts
Aguado, B. A., Walker, C. J., Grim, J. C., Schroeder, M. E., Batan, D., Vogt, B. J., Rodriguez, A. G., Schwisow, J. A., Moulton, K. S., Weiss, R. M., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.054108 · Cited by 87
Matters of the heart: Cellular sex differences
Walker, C. J., Schroeder, M. E., Aguado, B. A., Anseth, K. S., & Leinwand, L. A. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.04.010 · Cited by 74
Fleury, M.-A., & Clavel, M.-A. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.02.003 · Cited by 58
Sex-specific cell types and molecular pathways indicate fibro-calcific aortic valve stenosis
Myasoedova, V. A., Massaiu, I., Moschetta, D., Chiesa, M., Songia, P., Valerio, V., Alfieri, V., Capoulade, R., Trabattoni, D., Andreini, D., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.747714 · Cited by 32
Springhetti, P., Abdoun, K., & Clavel, M.-A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13144237 · Cited by 24
“Mechanisms underlying sex differences in fibrosis include different gene expression profiles and phenotypes [41].”
BackgroundLe Nezet, E., Tam, R., Li, Z., Gaudreault, N., Mathieu, P., Côté, N., Guisle, I., Thériault, S., Bossé, Y., & Clavel, M.-A. (2025) · CJC Open · doi:10.1016/j.cjco.2025.02.007 · Cited by 5
“MXRA5 was de fi ned as an anti-in fl ammatory and anti fi brotic protein, but its overexpression increased the expression of matrix-metalloproteases 2 and 9, 25,43 which both have been described in CAVS.”
Metadata
- Authors
- McCoy, C. M., Nicholas, D. Q., & Masters, K. S.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-07-10
- Volume
- 7
- Issue
- 7
- Pages
- e39980
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1995845341
- Cited by
- 85
- References
- 8
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.